Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis.
about
Clinical significance of hepatitis B e antigen level measurement during long-term lamivudine therapy in chronic hepatitis B patients with e antigen positive.Hepatitis B virus genotyping among chronic hepatitis B individuals with resistance to Lamivudine in shahrekord, iran.YMDD mutations in patients with chronic hepatitis B untreated with antiviral medicines.Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C.Effects of lamivudine on serum albumin levels correlate with pretreatment HBV-DNA levels in cirrhotic patients.Management of chronic hepatitis B: consensus guidelinestrans-Complementation of HBV rtM204I mutant replication by HBV wild-type polymerase.Construction and expression of eukaryotic plasmids containing lamivudine-resistant or wild-type strains of Hepatitis B Virus genotype C.Fatal liver failure caused by reactivation of lamivudine-resistant hepatitis B virus: a case report.Efficacy of lamivudine combined with adefovir dipivoxil versus entecavir monotherapy in patients with hepatitis B-associated decompensated cirrhosis: A meta-analysis.Antiviral treatment of hepatitis B virus-transgenic mice by a marine organism, Styela plicata.Quantitative detection of the M204V hepatitis B virus minor variants by amplification refractory mutation system real-time PCR combined with molecular beacon technology.Long-term follow-up of chronic hepatitis B after the emergence of mutations in the hepatitis B virus polymerase region.Chronic cirrhotic hepatitis B patients with a high incidence of hepatic decompensation after viral breakthrough with lamivudine-resistant mutants and during rescue treatment.
P2860
Q34017787-742ACA7C-1B70-44FA-91B4-1EAE92A572F8Q34068574-6299FDEB-2E84-4A47-85A8-C6E7CEB53481Q34604733-A371E576-C0E9-4478-A207-4E6E05951FDEQ34700034-73DE1A30-CDEA-40A0-8F43-BF50B0ABAE11Q35825117-7FFBC898-9896-44CF-801F-409C67BDBFA8Q36849343-47FD6737-3AA5-4735-8965-F4333F4B7545Q36897030-9F10C8ED-8294-4DC7-A08E-C1A1760EC2C9Q39966153-9F0A393A-4A75-49A5-93F2-C8A05B061E31Q40969094-51BA7549-D1A3-430E-8E93-764E7E9A28FBQ42245098-013FF367-5B34-4F81-94BA-98211D5E60BFQ42726101-D2E97169-8785-4109-82AB-5390A7803719Q43071697-8EF4BFF9-BE19-4B6F-B169-EFFA0699146AQ45273529-9A8A364E-61AE-4E9D-9887-3A1F6BF55A75Q46457817-9A2A374F-046B-4266-BE15-B9A1B91F6728
P2860
Fatal hepatic failure after emergence of the hepatitis B virus mutant during lamivudine therapy in a patient with liver cirrhosis.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Fatal hepatic failure after em ...... patient with liver cirrhosis.
@en
Fatal hepatic failure after em ...... patient with liver cirrhosis.
@nl
type
label
Fatal hepatic failure after em ...... patient with liver cirrhosis.
@en
Fatal hepatic failure after em ...... patient with liver cirrhosis.
@nl
prefLabel
Fatal hepatic failure after em ...... patient with liver cirrhosis.
@en
Fatal hepatic failure after em ...... patient with liver cirrhosis.
@nl
P2093
P1476
Fatal hepatic failure after em ...... patient with liver cirrhosis.
@en
P2093
P304
P356
10.1080/003655202317284309
P577
2002-03-01T00:00:00Z